含磷灰石-硅灰石玻璃陶瓷填料和双酚A-甲基丙烯酸缩水甘油酯树脂的生物活性骨水泥用于全髋关节置换术髋臼固定的长期随访临床试验结果
1996年在本院临床试验中,20例初次全髋关节置换术患者使用含磷灰石-硅灰石玻璃陶瓷粉和双酚A-甲基丙烯酸缩水甘油酯树脂的生物活性骨水泥固定髋臼假体。平均随访17.6年,4例髋臼假体出现影像学松动,平均7.8年;以髋臼假体翻修、影像学松动及最差情况为终点的10年生存率分别为94.7%、84.4%、85.0%,20年分别为70.0%、84.4%、62.8%。平均线性磨损率为每年0.068毫米。结论为长期结果不满意,材料脆性和操作性能需改进后才能成为骨水泥型全髋关节置换术髋臼固定的替代方法。
要点
- 20例初次全髋关节置换术使用生物活性骨水泥固定髋臼假体,平均随访17.6年。
- 4例髋臼假体出现影像学松动,平均7.8年;10年生存率94.7%、84.4%、85.0%。
- 平均线性磨损率为每年0.068毫米,长期结果不满意。
核心结论
- 使用含磷灰石-硅灰石玻璃陶瓷粉和双酚A-甲基丙烯酸缩水甘油酯树脂的生物活性骨水泥行初次全髋关节置换术的长期结果不满意。
- 该材料的脆性和较差的操控性能需在成为骨水泥型全髋关节置换术髋臼假体固定的替代方法前加以改进。
研究设计与样本
- 1996年在本院临床试验中,对20例(3男17女)初次全髋关节置换术患者使用生物活性骨水泥固定髋臼假体,平均年龄57.4岁(40至71岁),平均体重52.3 kg(39至64 kg),平均BMI 23.0 kg/m2(19.8至28.6),进行临床和影像学评估、生存分析及计算机辅助磨损分析。
主要发现
- 平均随访17.6年(1.5至21.1年)。
- 4例髋臼假体出现影像学松动,平均7.8年(1.5至20.7年)。
- 以髋臼假体翻修、髋臼假体影像学松动、以及将2例失访患者计入髋臼假体翻修的最差情况为终点的Kaplan-Meier生存率10年分别为94.7%、84.4%、85.0%,20年分别为70.0%、84.4%、62.8%。
- 磨损分析显示平均线性磨损率为每年0.068毫米。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: In the 1990s, a bioactive bone cement (BABC) containing apatite-wollastonite glass-ceramic (AW-GC) powder and bisphenol-a-glycidyl methacrylate resin was developed at our hospital. In 1996, we used BABC to fix the acetabular component in primary total hip arthroplasty (THA) in 20 patients as part of a clinical trial. The purpose of this study was to investigate the long-term results of primary THA using BABC. PATIENTS AND METHODS: A total of 20 patients (three men and 17 women) with a mean age of 57.4 years (40 to 71), a mean body weight of 52.3 kg (39 to 64), and a mean body mass index (BMI) of 23.0 kg/m2 (19.8 to 28.6) were evaluated clinically and radiologically. Survival analyses were undertaken, and wear analyses were carried out using a computer-aided method. RESULTS: The mean follow-up was 17.6 years (1.5 to 21.1). Radiological loosening occurred in four sockets with aseptic loosening at a mean of 7.8 years (1.5 to 20.7). Kaplan-Meier survival analyses using revision of the acetabular component, radiological loosening of the acetabular component, and the worst-case scenario with revision of the acetabular component to include the two patients lost to follow-up as endpoints yielded survival rates of 94.7%, 84.4%, and 85.0% at ten years, and 70.0%, 84.4%, and 62.8% at 20 years, respectively. Wear analysis revealed a mean linear wear rate of 0.068 mm per year. CONCLUSION: The long-term results of primary THAs using BABC were unsatisfactory. Its brittle nature and poor handling properties need to be improved before it becomes an alternative method of fixing the acetabular component in cemented THA. Cite this article: Bone Joint J 2019;101-B:787-792.
引用
- Goto K, Kuroda Y, Kawai T, et al. The use of a bioactive bone cement containing apatite-wollastonite glass-ceramic filler and bisphenol-a-glycidyl methacrylate resin for acetabular fixation in total hip arthroplasty: long-term follow-up results of a clinical trial. Bone Joint J. 2019. PMID: 31256668. doi:10.1302/0301-620X.101B7.BJJ-2018-1391.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。